Orexigenic Hypothalamic Peptides Behavior and Feeding

  • Jon F. Davis
  • Derrick L. Choi
  • Stephen C. Benoit
Chapter

Abstract

Orexigenic hypothalamic peptides have been studied extensively for their ability to regulate feeding behavior. The traditional contention regarding orexigenic peptide function ascribed that peptides produced within the Arc & LH exerted their effects on feeding through acting within local hypothalamic centers, with a major emphasis on the LH. However, reports over the last decade indicate that orexigenic peptides not only act within hypothalamic centers to regulate food intake but are also capable of affecting feeding through their actions at extra-hypothalamic centers, namely, within the brain’s endogenous reward circuitry. This observation expands the complexity of feeding behavior and indicates that feeding behavior can be manifested through reward processing. Moreover, studies from the field of addiction biology now indicate that orexigenic peptides are also capable of modulating drug taking behavior. Here, we consider, individually, four separate orexigenic hypothalamic peptide systems, their functional–anatomical location as well as the ability of each system to activate mesolimbic reward circuitry. As some have even suggested that a disruption within a hypothalamic neuropeptide system might underlie pathological overfeeding and addictive behaviors, this chapter also describes literature detailing the ability of orexigenic peptides to modulate addictive behavior with special emphasis given to relapse and reinstatement of psychostimulant use. Collectively, these ideas suggest that orexigenic peptides regulate reward processing, food reinforced behavior, and addictive behavior.

Keywords

Orexigenic food reinforced behavior mesolimbic dopamine 

References

  1. Abizaid A, Liu ZW, Andrews ZB, Shanabrough M, Borok E, Elsworth JD, et al. Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite. J Clin Invest. 2006;116:3229–39.PubMedCrossRefGoogle Scholar
  2. Adan RA, Gipsen W. Brain melanocortin receptors: from cloning to function. Peptides. 1997;8:1279–87.CrossRefGoogle Scholar
  3. Alvaro JD, Tatro JB, Quillan JM, Fogliano M, Eisenhard M, Lerner MR, et al. Morphine down regulates melanocortin-4 receptor expression in brain regions that mediate opiate addiction. Mol Pharmacol. 1996;3:583–91.Google Scholar
  4. Aoki C, Pickel VM. Neuropeptide Y-containing neurons in the rat striatum: ultrastructure and cellular relations with tyrosine hydroxylase-containing terminals and with astrocytes. Brain Res. 1988;459:205–25.PubMedCrossRefGoogle Scholar
  5. Bassareo V, Di Chiara G. Modulation of feeding-induced activation of mesolimbic dopamine transmission by appetitive stimuli and its relation to motivational state. Eur J Neurosci. 1999;11:4389–97.PubMedCrossRefGoogle Scholar
  6. Bassareo V, Di Chiara G. Differential influence of associative and nonassociative learning mechanism on the responsiveness of prefrontal and accumbal dopamine transmission to food stimuli in rats fed ad libitum. J Neurosci. 1997;17:851–61.PubMedGoogle Scholar
  7. Berridge KC. Food reward: brain substrates of wanting and liking. Neurosci Biobehav Rev. 1996;20:1–25.PubMedCrossRefGoogle Scholar
  8. Berthoud HR. Neural control of appetite: cross-talk between homeostatic and non-homeostatic systems. Appetite. 2004;43:315–7.PubMedCrossRefGoogle Scholar
  9. Borgland SL, Taha SA, Sarti F, Fields HL, Bonci A. Orexin A in the VTA is critical for the induction of synaptic plasticity and behavioral sensitization to cocaine. Neuron. 2006;49:589–601.PubMedCrossRefGoogle Scholar
  10. Boutrel B, Kenny PJ, Specio SE, Martin-Fardon R, Markou A, Koob GF, et al. Role for hypocretin in mediating stress-induced reinstatement of cocaine-seeking behavior. Proc Natl Acad Sci USA. 2005;102:19168–73.PubMedCrossRefGoogle Scholar
  11. Burdakov D, Gerasimenko O, Verkhratsky A. Physiological changes in glucose differentially modulate the excitability of hypothalamic melanin-concentrating hormone and orexin neurons in situ. J Neurosci. 2005;25:2429–33.PubMedCrossRefGoogle Scholar
  12. Cabeza de Vaca SHJ, Afroz T, Krahnne LL, Carr KD. Feeding, body weight and non-ingestive reward stimuli during and after 12 day continuous central infusions of melanocortin receptor ligands. Peptides. 2005;11:2314–21.CrossRefGoogle Scholar
  13. Cabeza de Vaca SKG, Carr KD. The melanocortin receptor agonist MTII augments the rewarding effects of amphetmaines in ad-libitum fed and food restricted rats. Psychopharmacology. 2002;1:77–85.CrossRefGoogle Scholar
  14. Cai XJ, Widdowson PS, Harrold J, Wilson S, Buckingham RE, Arch JR, et al. Hypothalamic orexin expression: modulation by blood glucose and feeding. Diabetes. 1999;48:2132–7.PubMedCrossRefGoogle Scholar
  15. Carr D, Kalivas PW. Orexin: a gatekeeper of addiction. Nat Med. 2006;12:274–6.PubMedCrossRefGoogle Scholar
  16. Carroll ME, Meisch RA. Increased drug reinforced behavior due to food deprivation. Adv Behav Pharmacol. 1984;4:47–88.Google Scholar
  17. Carroll ME, Stotz DC, Kliner DJ, Meisch RA. Self-administration of orally-delivered methohexital in rhesus monkeys with phencyclidine or pentobarbital histories: effects of food deprivation and satiation. Pharmacol Biochem Behav. 1984;20:145–51.PubMedCrossRefGoogle Scholar
  18. Clegg DJ, Air EL, Woods SC, Seeley RJ. Eating elicited by orexin-a, but not melanin-concentrating hormone, is opioid mediated. Endocrinology. 2002;143:2995–3000.PubMedCrossRefGoogle Scholar
  19. Cota D, Barrera JG, Seeley RJ. Leptin in energy balance and reward: two faces of the same coin? Neuron. 2006;51:678–80.PubMedCrossRefGoogle Scholar
  20. Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse BE, Weigle DS. A preprandial rise in plasma ghrelin levels suggests a role in meal initiation in humans. Diabetes. 2001;50:1714–9.PubMedCrossRefGoogle Scholar
  21. Di Chiara GAE, Tanda G, Candoni C. Drugs of abuse: biochemical surrogates of specific aspects of natural reward. Biochem Soc Symp. 1993;59:65–81.PubMedGoogle Scholar
  22. Diaz-Munoz M, Vazquez-Martinez O, Aguilar-Roblero R, Escobar C. Anticipatory changes in liver metabolism and entrainment of insulin, glucagon, and corticosterone in food-restricted rats. Am J Physiol Regul Integr Comp Physiol. 2000;279:R2048–56.PubMedGoogle Scholar
  23. Di Chiara G, Imperato A. Drugs abused by humans preferentially increase dopamine concentraions in the mesolimbic system of freely moving rats. Proc Natl Acad Sci. 1988;85:5274–8.PubMedCrossRefGoogle Scholar
  24. Drazen DL, Vahl TP, D’Alessio DA, Seeley RJ, Woods SC. Effects of a fixed meal pattern on ghrelin secretion: evidence for a learned response independent of nutrient status. Endocrinology. 2006;147:23–30.PubMedCrossRefGoogle Scholar
  25. Duarte C, Biala G, Le Bihan C, Hamon M, Thiebot MH. Respective roles of dopamine D2 and D3 receptors in food-seeking behaviour in rats. Psychopharmacology (Berlin). 2003;166:19–32.Google Scholar
  26. Dube MG, Horvath TL, Kalra PS, Kalra SP. Evidence of NPY Y5 receptor involvement in food intake elicited by orexin A in sated rats. Peptides. 2000;21:1557–60.PubMedCrossRefGoogle Scholar
  27. Emson PC, Koob GF. The origin and distribution of dopamine-containing afferents to the rat frontal cortex. Brain Res. 1978;142:249–67.PubMedCrossRefGoogle Scholar
  28. Fadel J, Deutch AY. Anatomical substrates of orexin-dopamine interactions: lateral hypothalamic projections to the ventral tegmental area. Neuroscience. 2002;111:379–87.PubMedCrossRefGoogle Scholar
  29. Figlewicz DP, Higgins MS, Ng-Evans SB, Havel PJ, Ng-Evans SB, Havel PJ. Leptin reverses sucrose conditioned place preference in food restricted rats. Physiol Behav. 2001;1–2:229–34.CrossRefGoogle Scholar
  30. Fuxe K, Hokfelt T. On the existence of dopaminergic and noradrenergic mechanisms in the control of hormone releasing and inhibitory factor secretion from the median eminence. J Anat. 1972;111:475–6.PubMedGoogle Scholar
  31. Guan XM, Yu H, Palyha OC, McKee KK, Feighner SD, Sirinathsinghji DJ, et al. Distribution of mRNA encoding the growth hormone secretagogue receptor in brain and peripheral tissues. Brain Res Mol Brain Res. 1997;48:23–9.PubMedCrossRefGoogle Scholar
  32. Hagan MM, Benoit SC, Rushing PA, Pritchard LM, Woods SC, Seeley RJ. Immediate and prolonged patterns of Agouti related peptide-(83-132) induced c-fos activation in hypothalamic and extrahypothalamic sites. Endocrinology. 2001a;3:1050–6.CrossRefGoogle Scholar
  33. Hagan MM, Rushing PA, Benoit SC, Woods SC, Seeley RJ. Opioid receptor involvement in the effect of AgRP-(83-132) on food intake and food selection. Am J Physiol Reg Integr Comp Physiol. 2001b;1:R814–21.Google Scholar
  34. Harris GC, Wimmer M, Aston-Jones G. A role for lateral hypothalamic orexin neurons in reward seeking. Nature. 2005;437:556–9.PubMedCrossRefGoogle Scholar
  35. Harris GC, Wimmer M, Randall-Thompson JF, Aston-Jones G. Lateral hypothalamic orexin neurons are critically involved in learning to associate an environment with morphine reward. Behav Brain Res. 2007;183:43–51.PubMedCrossRefGoogle Scholar
  36. Holland PC, Petrovich GD. A neural systems analysis of the potentiation of feeding by conditioned stimuli. Physiol Behav. 2005;86:747–61.PubMedCrossRefGoogle Scholar
  37. Holst B, Schwartz TW. Constitutive ghrelin receptor activity as a signaling set-point in appetite regulation. Trends Pharmacol Sci. 2004;25:113–7.PubMedCrossRefGoogle Scholar
  38. Holst B, Cygankiewicz A, Jensen TH, Ankersen M, Schwartz TW. High constitutive signaling of the ghrelin receptor – identification of a potent inverse agonist. Mol Endocrinol. 2003;17:2201–10.PubMedCrossRefGoogle Scholar
  39. Hsu R, Taylor JR, Newton SS, Alvaro JD, Haile C, Han G, et al. Blockade of melanocortin transmission inhibits cocaine reward. Eur J Neurosci. 2005;8:2233–42.CrossRefGoogle Scholar
  40. Kalra SP, Dube MG, Sahu A, Phelps CP, Kalra PS. Neuropeptide Y secretion increases in the paraventricular nucleus in association with increased appetite for food. Proc Natl Acad Sci USA. 1991;88:10931–5.PubMedCrossRefGoogle Scholar
  41. Kelley AE, Berridge KC. The neuroscience of natural rewards: relevance to addictive drugs. J Neurosci. 2002;22:3306–11.PubMedGoogle Scholar
  42. Korotkova TM, Sergeeva OA, Eriksson KS, Haas HL, Brown RE. Excitation of ventral tegmental area dopaminergic and nondopaminergic neurons by orexins/hypocretins. J Neurosci. 2003;23:7–11.PubMedGoogle Scholar
  43. Lawrence AJ, Cowen MS, Yang HJ, Chen F, Oldfield B. The orexin system regulates alcohol-seeking in rats. Br J Pharmacol. 2006;148:752–9.PubMedCrossRefGoogle Scholar
  44. Lopez M, Seoane L, Garcia MC, Lago F, Casanueva FF, Senaris R, et al. Leptin regulation of prepro-orexin and orexin receptor mRNA levels in the hypothalamus. Biochem Biophys Res Commun. 2000;269:41–5.PubMedCrossRefGoogle Scholar
  45. Lu D, Willard D, Patel I, et al. Agouti protein is an antagonist of the melanocyte-stimulating-hormone receptor. Nature. 1994;371:799–802.PubMedCrossRefGoogle Scholar
  46. Marcus JN, Aschkenasi CJ, Lee CE, Chemelli RM, Saper CB, Yanagisawa M, et al. Differential expression of orexin receptors 1 and 2 in the rat brain. J Comp Neurol. 2001;435:6–25.PubMedCrossRefGoogle Scholar
  47. Masuda Y, Tanaka T, Inomata N, Ohnuma N, Tanaka S, Itoh Z, et al. Ghrelin stimulates gastric acid secretion and motility in rats. Biochem Biophys Res Commun. 2000;276:905–8.PubMedCrossRefGoogle Scholar
  48. Mendoza J, Angeles-Castellanos M, Escobar C. Entrainment by a palatable meal induces food-anticipatory activity and c-Fos expression in reward-related areas of the brain. Neuroscience. 2005;133:293–303.PubMedCrossRefGoogle Scholar
  49. Mistlberger RE. Circadian food-anticipatory activity: formal models and physiological mechanisms. Neurosci Biobehav Rev. 1994;18:171–95.PubMedCrossRefGoogle Scholar
  50. Mizuno TM, Makimura H, Silverstein J, Roberts JL, Lopingco T, Mobbs CV. Fasting regulates hypothalamic neuropeptide Y, agouti-related peptide, and proopiomelanocortin in diabetic mice independent of changes in leptin or insulin. Endocrinology. 1999;140:4551–7.PubMedCrossRefGoogle Scholar
  51. Mountjoy MG, Robbins LS, Mortrud M, Cone R. The cloning of a family of genes that encode the melanocortin receptors. Science. 1992;257:1248–51.PubMedCrossRefGoogle Scholar
  52. Muschamp JW, Dominguez JM, Sato SM, Shen RY, Hull EM. A role for hypocretin (orexin) in male sexual behavior. J Neurosci. 2007;27:2837–45.PubMedCrossRefGoogle Scholar
  53. Carr KD, Kutchukhidze N. Chronic food restriction increases fos-like immunoreactivity (FLI) induced in rat forebrain by amphetamine. Brain Res. 2000;861:88–96.PubMedCrossRefGoogle Scholar
  54. Nair SG, Golden SA, Shaham Y. Differential effects of the hypocretin 1 receptor antagonist SB 334867 on high-fat food self-administration and reinstatement of food seeking in rats. Br J Pharmacol. 2008;154:406–16.PubMedCrossRefGoogle Scholar
  55. Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, et al. A role for ghrelin in the central regulation of feeding. Nature. 2001;409:194–8.PubMedCrossRefGoogle Scholar
  56. Narita M, Nagumo Y, Hashimoto S, Narita M, Khotib J, Miyatake M, et al. Direct involvement of orexinergic systems in the activation of the mesolimbic dopamine pathway and related behaviors induced by morphine. J Neurosci. 2006;26:398–405.PubMedCrossRefGoogle Scholar
  57. Nestler EJ. Common molecular and cellular substrates of addiction and memory. Neurobiol Learn Mem. 2002;78:637–47.PubMedCrossRefGoogle Scholar
  58. Panskepp J, Reilly P, Bishop P, Meeker RB, Vilberg TR, Kastin AJ. Effects of alpha-MSH on motivation, vigilance, and brain respiration. Pharmacol Biochem Behav. 1976;1(Suppl):59–64.Google Scholar
  59. Papp M. Different effects of short- and long-term treatment with imipramine on the apomorphine- and food-induced place preference conditioning in rats. Pharmacol Biochem Behav. 1988;30:889–93.PubMedCrossRefGoogle Scholar
  60. Peyron C, Tighe DK, van den Pol AN, de Lecea L, Heller HC, Sutcliffe JG, et al. Neurons containing hypocretin (orexin) project to multiple neuronal systems. J Neurosci. 1998;18:9996–10015.PubMedGoogle Scholar
  61. Robinson TE, Berridge K. The neural basis of drug craving and incentive-sensitization theory of addiction. Brain Res Brain Res Rev. 1993;18:247–91.PubMedCrossRefGoogle Scholar
  62. Rodgers RJ, Halford JC, Nunes de Souza RL, Canto de Souza AL, Piper DC, Arch JR, et al. SB-334867, a selective orexin-1 receptor antagonist, enhances behavioural satiety and blocks the hyperphagic effect of orexin-A in rats. Eur J Neurosci. 2001;13:1444–52.PubMedCrossRefGoogle Scholar
  63. Rogers RD, Ramnani N, Mackay C, Wilson JL, Jezzard P, Carter CS, et al. Distinct portions of anterior cingulate cortex and medial prefrontal cortex are activated by reward processing in separable phases of decision-making cognition. Biol Psychiatry. 2003;55:594–602.CrossRefGoogle Scholar
  64. Rossi M, Kim MS, Morgan DG, Small CJ, Edwards CM, Sunter D, et al. A C-terminal fragment of Agouti related protein increases feeding and antagonizes the effect of alpha-melanocyte stimulating hormone in vivo. Endocrinology. 1998;10:4428–31.CrossRefGoogle Scholar
  65. Sakurai T. The neural circuit of orexin (hypocretin): maintaining sleep and wakefulness. Nat Rev Neurosci. 2007;8:171–81.PubMedCrossRefGoogle Scholar
  66. Sakurai T, Amemiya A, Ishii M, Matsuzaki I, Chemelli RM, Tanaka H, et al. Orexins and orexin receptors: a family of hypothalamic neuropeptides and G protein-coupled receptors that regulate feeding behavior. Cell. 1998;92:573–85.PubMedCrossRefGoogle Scholar
  67. Scammell TE, Saper CB. Orexin, drugs and motivated behaviors. Nat Neurosci. 2005;8:1286–8.PubMedCrossRefGoogle Scholar
  68. Schroeder BE, Binzak JM, Kelley AE. A common profile of prefrontal cortical activation following exposure to nicotine- or chocolate-associated contextual cues. Neuroscience. 2001;105:535–45.PubMedCrossRefGoogle Scholar
  69. Schwartz MW, Figlewicz DP, Baskin DG, Woods SC, Porte Jr D. Insulin in the brain: a hormonal regulator of energy balance. Endocr Rev. 1992;13:387–414.PubMedGoogle Scholar
  70. Schwartz MW, Woods SC, Porte Jr D, Seeley RJ, Baskin DG. Central nervous system control of food intake. Nature. 2000;6778:661–71.Google Scholar
  71. Sesack SR, Pickel VM. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol. 1992;320:145–60.PubMedCrossRefGoogle Scholar
  72. Sesack SR, Deutch AY, Roth RH, Bunney BS. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol. 1989;290:213–42.PubMedCrossRefGoogle Scholar
  73. Sugino T, Hasegawa Y, Kikkawa Y, Yamaura J, Yamagishi M, Kurose Y, et al. A transient ghrelin surge occurs just before feeding in a scheduled meal-fed sheep. Biochem Biophys Res Commun. 2002;295:255–60.PubMedCrossRefGoogle Scholar
  74. Sutton GM, Perez-Tilve D, Nogueiras R, Fang J, Kim J, Cone R, et al. The melanocortin-3 receptor is required for entrainment to meal intake. J Neurosci. 2008;48:12946–55.CrossRefGoogle Scholar
  75. Thorpe AJ, Cleary JP, Levine AS, Kotz CM. Centrally administered orexin A increases motivation for sweet pellets in rats. Psychopharmacology (Berlin). 2005;182:75–83.CrossRefGoogle Scholar
  76. Tolle V, Bassant MH, Zizzari P, Poindessous-Jazat F, Tomasetto C, Epelbaum J, et al. Ultradian rhythmicity of ghrelin secretion in relation with GH, feeding behavior, and sleep-wake patterns in rats. Endocrinology. 2002;143:1353–61.PubMedCrossRefGoogle Scholar
  77. Toshinai K, Date Y, Murakami N, Shimada M, Mondal MS, Shimbara T, et al. Ghrelin-induced food intake is mediated via the orexin pathway. Endocrinology. 2003;144:1506–12.PubMedCrossRefGoogle Scholar
  78. Tschop M, Smiley DL, Heiman ML. Ghrelin induces adiposity in rodents. Nature. 2000;407:908–13.PubMedCrossRefGoogle Scholar
  79. Tschop M, Wawarta R, Riepl RL, Friedrich S, Bidlingmaier M, Landgraf R, et al. Post-prandial decrease of circulating human ghrelin levels. J Endocrinol Invest. 2001;24:RC19–21.PubMedGoogle Scholar
  80. Tzschentke TM. Measuring reward with the conditioned place preference paradigm: a comprehensive review of drug effects, recent progress and new issues. Prog Neurobiol. 1998;56:613–72.PubMedCrossRefGoogle Scholar
  81. Volkow ND, Wise RA. How can drug addiction help us understand obesity? Nat Neurosci. 2005;8:555–60.PubMedCrossRefGoogle Scholar
  82. Weingarten HP. Conditioned cues elicit feeding in sated rats: a role for learning in meal initiation. Science. 1983;220:431–3.PubMedCrossRefGoogle Scholar
  83. Wise RA. Catecholamine theories of reward: a critical review. Brain Res. 1978;152:215–47.PubMedCrossRefGoogle Scholar
  84. Wise RA. Brain reward circuitry: insights from unsensed incentives. Neuron. 2002;36:229–40.PubMedCrossRefGoogle Scholar
  85. Wise RA. Dopamine and food reward: back to the elements. Am J Physiol Regul Integr Comp Physiol. 2004;286:R13.PubMedCrossRefGoogle Scholar
  86. Wise RA, Schwartz HV. Pimozide attenuates acquisition of lever-pressing for food in rats. Pharmacol Biochem Behav. 1981;15:655–6.PubMedCrossRefGoogle Scholar
  87. Wise RA, Bozarth MA. A psychomotor stimulant theory of addiction. Psychol Rev. 1987;94:469–92.PubMedCrossRefGoogle Scholar
  88. Xue G, Lu Z, Levin I, Weller J, Li X, Bechara A. Functional dissociations of risk and reward processing in the medial prefrontal cortex. Cereb Cortex. 2009;19:1019–27. Epub 2008.PubMedCrossRefGoogle Scholar
  89. Yamanaka A, Kunii K, Nambu T, Tsujino N, Sakai A, Matsuzaki I, et al. Orexin-induced food intake involves neuropeptide Y pathway. Brain Res. 2000;859:404–9.PubMedCrossRefGoogle Scholar
  90. Zheng H, Berthoud HR. Eating for pleasure or calories. Curr Opin Pharmacol. 2007;7:607–12.PubMedCrossRefGoogle Scholar
  91. Zheng H, Patterson LM, Berthoud HR. Orexin signaling in the ventral tegmental area is required for high-fat appetite induced by opioid stimulation of the nucleus accumbens. J Neurosci. 2007;27:11075–82.PubMedCrossRefGoogle Scholar
  92. Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, et al. Mice lacking ghrelin receptors resist the development of diet-induced obesity. J Clin Invest. 2005;115:3564–72.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Jon F. Davis
    • 1
  • Derrick L. Choi
  • Stephen C. Benoit
  1. 1.Department of PsychiatryUniversity of CincinnatiCincinnatiUSA

Personalised recommendations